Real Life Sciences Japan to attend 19th International Conference of Pharmaceutical Medicine (ICPM)

Real Life Sciences Japan will be exhibiting at ICPM 2018 and we are excited to see what is in store for the booming pharma space in Japan.

The theme for this year is ‘The Future of Medicines Development’.

Japan possess one of the most successful medical industries in the world. However, with its fast aging population, it is likely to drive the demand for medicine in the years to come.

ICPM 2018 will highlight the markets that are growing within pharma to meet the escalating demands for new and improved drugs, devices and services.

 

What can you look out for?

Pharmaceutical Medicine and Clinical Research

Japan continues to be one of the largest pharmaceutical markets in the world despite the challenging business landscape due to demographics. According to the latest official figures from the Ministry of Health, Labour and Welfare (MHLW)’s Annual Pharmaceutical Production Statistics, the Japanese market for prescription and non-prescription pharmaceuticals in 2017 have summed up to $95 billion (up 2.3% from 2016 in yen terms).

Pharmacovigilance

Japan’s Pharmacovigilance is the process and science of monitoring the safety of medication and taking action to reduce the risks whilst increase the benefits of medication. Currently, medicinal products manufactured in Japan are subject to a strict testing to enhance the assessment of their quality, efficacy and safety before being authorised.

Big data in Medicine’s Development

The current environment for health and medical data in Japan are in siloes – for instance, by type of disease, service provider or region. It is seen to be less cost effective to collect data which are large and deep enough to spin-off the development of new drugs or measure the effectiveness of new treatments. However, this is a trend that would likely change in the coming years.

Artificial Intelligence

More pharma companies in Japan are starting to venture into areas such as AI in drug discovery, health services and even medical devices. With the aging population, AI serves as a support and form of assistance to ease the burden in shortage of medical practitioners and specialists, along with pharma manufacturers.

 

When is ICPM 2018 happening?

Date: September 27 (Thursday) - 29 (Saturday)

Venue: The University of Tokyo Ito International Academic Research Center (for 27th – 28th), Tokyo University of Medical Education and research building Tetsumon Memorial Auditorium (29th )

Our Booth number: 4

The pharma and medical sector is currently undergoing great changes in Japan. To get updated on the latest industry trends as well as contribute to the industry in terms of talent insights, Real Life Sciences Japan will be having a booth at this much anticipated event. If you’d like to find out more, get connected with us at [email protected] for more updates. You may also visit our website at www.realstaffing.com for more industry related insights. For more information about the event, do also visit https://www.icpm2018tokyo.com/message.html.

Keep a look out for more updates closer to the event and we hope to see you there!

SThree COVID-19 Update

19 Mar 2020

Our purpose is to bring skilled people together to build the future, and this has never felt more important than it does today

How to onboard new employees successfully remotely

06 Apr 2020

During this challenging times, companies are faced with a challenge. How can you create a successful digital onboarding process? We pulled together a few tips to help you out.

Five useful questions to ask on your first day in a new job

01 Mar 2019

Your first day in a new job can be tough - our recruitment experts at Real Staffing put together five questions that are useful to ask on your first day!

Real Life Sciences will attend DIA 2019

01 Nov 2019

Real Life Sciences will be partnering with DIA (Drug Information Association) Japan’s Annual Meeting this year again. We have established a strong partnership with DIA around the world, including Europe, the United States, and Singapore, and we are pleased to be a part of a leading community of professionals within the life science industry.

Tags: DIA PHARMA